MichelleElizabethMeliskoMD
Oncology • San Francisco, CABreast Cancer, Hematologic Oncology, Hospice & Palliative
Clinical Professor, Medicine, UCSF School of Medicine
Dr. Melisko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-7070Fax+1 415-353-9898
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2000 - 2003
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1997 - 2000
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1997
Certifications & Licensure
CA State Medical License 1998 - 2026- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases Start of enrollment: 2005 Feb 01
- Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients Start of enrollment: 2007 Mar 01
- Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 399 citationsFully Automated Echocardiogram Interpretation in Clinical PracticeJeffrey Zhang, Sravani Gajjala, Pulkit Agrawal, Geoffrey H. Tison, Laura A. Hallock
Circulation. 2018-10-16 - 108 citationsExhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.Manuela Terranova-Barberio, Nela Pawlowska, Mallika Sachdev Dhawan, Mark M. Moasser, Amy Jo Chien
Nature Communications. 2020-07-17 - 68 citationsNCCN guidelines® insights survivorship, version 1.2016 featured updates to the NCCN GuidelinesCrystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Gregory A. Broderick
Journal of the National Comprehensive Cancer Network. 2016-06-01
Press Mentions
ESMO Breast Cancer Roundtable: Episode 5November 13th, 2019
OncLive® Presents the Latest State of the Science Summit™ on Breast CancerSeptember 25th, 2018
Expert Raises QoL Concerns with Adjuvant Hormonal Therapy in ER+ Breast CancerOctober 31st, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
